2014, Number 4
<< Back Next >>
CorSalud 2014; 6 (4)
Predictors of success of electrical cardioversion for atrial fibrillation
Cruz CM, Pérez RT, Méndez RA
Language: Spanish
References: 25
Page: 280-287
PDF size: 505.38 Kb.
ABSTRACT
Introduction: Electrical cardioversion is an effective therapeutic procedure to restore
sinus rhythm in atrial fibrillation, and its success has been related to different variables.
Objective: To relate clinical, electrical and echocardiographic variables to the success of electrical cardioversion for atrial fibrillation and to the amount of energy used to restore sinus rhythm.
Method: A prospective longitudinal study was conducted in 82 patients with atrial fibrillation who were treated with elective electrical cardioversion.
Results: Electrical cardioversion was successful in 81.7% of patients. Heart failure (p=0.000), mitral valve disease (p=0.001), previous arrhythmic events (p=0.005), increased time to progression (p=0.019), increased left ventricular telediastolic diameter (p=0.000), and increased diameter, area and pressure of the left atrium (p=0.000, p=0.008, p=0.000, respectively), were associated with a decrease in the success of the shock. Left ventricular ejection fraction was the only independent predictor of success (OR 2.1; 95% CI, p=0.048). The use of a higher amount of energy was related to previous arrhythmic events (p=0.000), decreased left ventricular ejection fraction (p=0.000), older age (p=0.037), increased time to progression (p=0.02), increased left ventricular diameter (p=0.000), increased diameter, area and pressure of the left atrium (p=0.000, p=0.000 and p=0.000, respectively) and increased area of the right atrium (p=0.016).
Conclusions: The left ventricular ejection fraction is an independent predictor of the success of electrical cardioversion for atrial fibrillation. The presence of biatrial remodeling, left ventricular dysfunction, previous arrhythmic events and a long progression require higher amounts of energy to restore sinus rhythm.
REFERENCES
Go AS, Hylek EM, Phillips KA, Selby JV, Henault LE , Chang Y, et al. Prevalence of diagnosed atrial fi-brillation in adults: national implications for rhythm management and stroke prevention: the anticoa-gulation and risk factors in atrial fibrillation (ATRIA) study. JAMA. 2001;285(18):2370-5.
Kannell WB, Wolf PA, Benjamin EJ, Levy D. Pre-valence, incidence, prognosis and predisposing con-ditions for atrial fibrillation: population-based esti-mates. Am J Cardiol. 1998;82(7 Suppl 1):2-9.
Le Heuzey JY, Paziaud O, Piot O, Said MA, Copie X, Lavergne T, et al. Cost of care distribution in atrial fibrillation patients: the COCAF study. Am Heart J. 2004;147(1):121-6.
Arnar DO, Danielsen R. Factors predicting mainten-ance of sinus rhythm after direct current cardiover-sion of atrial fibrillation and flutter: a reanalysis with recently acquired data. Cardiology. 1996; 87(3):181-8.
Blich M, Edoute Y. Electrical cardioversion for per-sistent or chronic atrial fibrillation: Outcome and clinical factors predicting short and long term success rate. Int J Cardiol. 2006;107(3):389-94.
Elhendy A, Gentile F, Khandheria BK, Hammill SC, Gersh BJ, Bailey KR, et al. Predictors of unsuccessful electrical cardioversion in atrial fibrillation. Am J Cardiol. 2002;89(1):83-6.
Cakulev I, Efimod IR, Waldo AL. Cardioversion: Past, present, and future. Circulation. 2009;120(16): 1623-32.
Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cush-man M, Fried LP, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96(7):2455-61.
Fumagalli S, Boncinelli L, Bondi E, Caleri V, Gatto S, Di Bari M, et al. Does advanced age affect the immediate and long-term results of direct-current external cardioversion of atrial fibrillation? J Am Geriatr Soc. 2002;50(7):1192-7.
10.Berry C, Rae A, Taylor J, Brady AJ. Atrial fibrillation in the elderly. Br J Cardiol. 2003;10(5):373-8.
11.Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, et al. Temporal relations of atrial fi-brillation and congestive heart failure and their joint influence in mortality: The Framingham Heart Study. Circulation. 2003;107(23):2920-5.
12.Disertori M, Lombardi F, Barlera S, Latini R, Maggio-ni AP, Zeni P, et al. Clinical predictors of atrial fi-brillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial. Am Heart J. 2010;159(5):857-63.
13.Kuppahally SS, Foster E, Shoor S, Steimle AE. Short-term and long-term success of electrical cardio-version in atrial fibrillation in managed care system. Int Arch Med [Internet]. 2009[citado 9 Feb 2014]; 2:39. Disponible en: http://www.intarchmed.com/content/pdf/1755-7682-2-39.pdf
14.Bailey GW, Braniff BA, Hancock EW, Cohn KE. Relation of left atrial pathology to atrial fibrillation in mitral valvular disease. Ann Intern Med. 1968; 69(1):13-20. 15.Allessie M, Ausma J, Schotten U. Electrical, con-tractile and structural remodeling during atrial fi-brillation. Cardiovasc Res. 2002;54(2):230-46.
16.Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, et al. Amiodarone to prevent re-currence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med. 2000; 342(13):913-20.
17.Capucci A, Villani GQ, Aschieri D, Rosi A, Piepoli MF. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur Heart J. 2000;21(1):66-73.
18.Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atriall fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92(7):1954-68.
19.Crijns HJ, Tjeerdsma G, de Kam PJ, Boomsma F, van Gelder IC, van den Berg MP, et al. Prognostic value of the presence and development of atrial fi-brillation in patients with advanced chronic heart failure. Eur Heart J. 2006;21(15):1238-45.
20.Dittrich HC, Erickson JS, Schneiderman T, Blacky AR, Savides T, Nicod PH. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol. 1989;63(3):193-7.
21.Frick M, Frykman V, Jensen-Urstad M, Ostergren J, Rosenqvist M. Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation. Clin Cardiol. 2001;24(3):238-44.
22.Hobbs WJ, Fynn S, Todd DM, Wolfson P, Galloway M, Garratt CJ. Reversal of atrial electrical remo-delling after cardioversion of persistent atrial fi-brillation in humans. Circulation. 2000;101(10): 1145-51.
23.Alt E, Ammer R, Lehmann G, Pütter K, Ayers GM, Pasquantonio J, et al. Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardio-version in patients treated with oral sotalol. Am Heart J. 1997;134(3):419-25.
24.Tebbe U, Carlsson J, Seidl K, Jansen W, Schuster HP, Elsner M, et al. Cardioversion in atrial fibrillation. Results and complications in 1.152 prospective patients. Study Group of the Working Society of Leading Cardiologic Hospital Physicians. Med Klin (Munich). 1995;90(12):681-7.
25.Roijer A, Meurling CJ, Eskilsson J, Olsson B. Left atrial appendage outflow velocity index is superior to conventional criteria for prediction of main-tenance of sinus rhythm after cardioversion. An echocardiographic study in patients with atrial fibrillation of a few months' duration. Scand Car-diovasc J. 2001;35(2):119-24.
26.Jalife J. ¿Por qué es la aurícula izquierda tan im-portante en el mecanismo de la fibrilación auricular crónica? RIA [Internet]. 2009[citado 9 Feb 2014];1(1):3-26. Disponible en: http://www.ria-online.com/webapp/uploads/15_layouted_ria_riaar001-v10_20091103.pdf